Ergoteles LLC Avalo Therapeutics, Inc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$3.0 - $10.45 $853,707 - $2.97 Million
284,569 New
284,569 $142,000
Q4 2021

Feb 14, 2022
SELL
$19.68 - $28.68 $777,360 - $1.13 Million
-39,500 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$26.16 - $40.68 $1.03 Million - $1.61 Million
39,500 New
39,500 $86,000

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0
View Full List

About Avalo Therapeutics, Inc.

AVTX Quotes by TradingView
  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $84.9M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email